CPC C07D 307/94 (2013.01) [A61K 31/343 (2013.01); A61K 31/4155 (2013.01); A61K 31/4245 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 407/12 (2013.01); C07D 413/04 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01)] | 14 Claims |
1. A solid oral dosage form comprising a compound of general formula (1) or a pharmacologically acceptable salt thereof:
wherein the symbols in the formula are defined below:
R1: a C1-C6 alkyl group or a hydroxyC1-C6 alkyl group,
R2: a C1-C6 alkyl group,
A: a 5-membered aromatic heterocycle having bonds and having 1-4 atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, or an oxygen atom, and
R3: if A is a 5-membered aromatic heterocycle having bonds and having 1-4 atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, then R3 is a C1-C6 alkyl group, a hydroxyC1-C6 alkyl group or a C1-C6 alkoxyC1-C6 alkyl group; and if A is an oxygen atom, then R3 is a hydroxyC1-C6 alkyl group or a C1-C6 alkoxyC1-C6 alkyl group.
|